| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |